Get the app!
Back to Trades

Haddadin Yezan Munther

DirectorCIK 0001718004

Largest Purchase

$24.1K

Outlook Therapeutics, Inc. (OTLK)

Jun 3

Profile

Filings
3
Buy transactions
2
Sell transactions
0
Companies
1
Active
2025–2026

Haddadin Yezan Munther, Director, has filed 3 reports across 1 company, totaling $439.0K in disclosed volume. The predominance of buying ($39.1K in purchases vs. $0 in sales) may reflect confidence in the underlying companies. All data sourced from SEC Form 3, 4, and 5 filings.

Trading History

3 loaded
Jun 3OTLK
Outlook Therapeutics, Inc.
Haddadin Yezan MuntherDirectorBuy$24.1K
May 27OTLK
Outlook Therapeutics, Inc.
Haddadin Yezan MuntherDirectorBuy$15.0K
Oct 3OTLK
Outlook Therapeutics, Inc.
Haddadin Yezan MuntherDirectorOther$0

3 filings